The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease.

about

The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease.

Item

http://www.wikidata.org/entity/Q36073903

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease.

@ast

The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease.

@en

type

Item

label

The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease.

@ast

The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease.

@en

prefLabel

The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease.

@ast

The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease.

@en

P1476

The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease.

@en

P2093

Benjamin O Yarnoff

http://www.w3.org/2001/XMLSchema#string

Desmond E Williams

http://www.w3.org/2001/XMLSchema#string

Meda E Pavkov

http://www.w3.org/2001/XMLSchema#string

Nilka R Burrows

http://www.w3.org/2001/XMLSchema#string

Siobhan A Simpson

http://www.w3.org/2001/XMLSchema#string

Sundar S Shrestha

http://www.w3.org/2001/XMLSchema#string

Thomas J Hoerger

http://www.w3.org/2001/XMLSchema#string

Xiaohui Zhuo

http://www.w3.org/2001/XMLSchema#string

P2860

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

Higher doses of erythropoietin-stimulating agents and hyporesponsiveness to their effects are associated with increased mortality among prevalent hemodialysis patients.

Deriving an algorithm to convert the eight mean SF-36 dimension scores into a mean EQ-5D preference-based score from published studies (where patient level data are not available).

Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia.

Transfusion burden among patients with chronic kidney disease and anemia.

Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease.

Cost-effectiveness of screening for microalbuminuria among African Americans.

Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis.

Cost-effectiveness of echocardiography to identify intracardiac thrombus among patients with first stroke or transient ischemic attack.

P304

e0157323

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0157323

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27404556

http://www.w3.org/2001/XMLSchema#string

P932

4942058

http://www.w3.org/2001/XMLSchema#string